EQH vs FHN

Equitable Holdings exhibits severe financial distress as evidenced by a weak Piotroski F-Score of 2/9 and a negative ROE of -38.87%. While analysts maintain a 'strong_buy' rating with a target of $57.46, this is sharply contradicted by a 0/100 technical trend, aggressive insider selling, and a consistent track record of earnings misses (0/4 in the last year). The combination of negative revenue growth (-14.20%) and a negative Price/Book ratio suggests a value trap rather than a value opportunity.

FHN presents a stark contrast between attractive valuation and deteriorating fundamental health, highlighted by a weak Piotroski F-Score of 2/9. While the current price of $24.21 is a discount to both the Graham Number ($28.16) and the growth-based Intrinsic Value ($58.7), the low health score and bearish insider activity suggest significant underlying risks. These concerns are partially offset by strong earnings growth (29.3% YoY) and a consistent track record of beating analyst estimates. Consequently, the stock is a high-risk value play where growth metrics clash with poor deterministic health indicators.